Bright Minds Biosciences
DRUG · CANADIAN
$52.48−$0.21 (−0.40%)TodayMarket closed ·
Prev close $52.69
Who owns DRUG
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 64.3% of DRUG’s shares.
- Janus Henderson Investors13.7%
- McDonald (Ian)10.2%
- Cormorant Asset Management, LP9.1%
- Vivo Capital, LLC5.7%
- Next 6 largest institutions25.6%
- All other shareholders35.7%
| Holder | Shares | % of shares |
|---|---|---|
| Janus Henderson Investors | 1.35M | 13.68% |
| McDonald (Ian) | 1.00M | 10.19% |
| Cormorant Asset Management, LP | 900.00K | 9.13% |
| Vivo Capital, LLC | 557.17K | 5.65% |
| Vestal Point Capital, LP | 545.00K | 5.53% |
| Braidwell LP | 483.82K | 4.91% |
| Driehaus Capital Management, LLC | 433.38K | 4.40% |
| BlackRock Institutional Trust Company, N.A. | 385.17K | 3.91% |
| Balyasny Asset Management LP | 345.05K | 3.50% |
| Adage Capital Management, L.P. | 335.00K | 3.40% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| iShares Russell 2000 ETF | 193.58K | 1.96% |
| Janus Henderson Horizon Biotechnology | 166.05K | 1.68% |
| Eventide Healthcare & Life Sciences Fund | 130.01K | 1.32% |
| Driehaus US Micro Cap Equity Fund | 107.14K | 1.09% |
| BlackRock Health Sciences Opportunities Portfolio | 95.66K | 0.97% |
Insider trades
Form 4 filings by officers, directors and large holders
Over the last 6 months, insiders sold $9.79M (1 trade) of DRUG on the open market, with no buys.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Cormorant Asset Management, LP | Sale | 109.33K | $9.79M |
Short interest
Settled Sep 30, 2026
- Shares short
- 882.83K
- Days to cover
- 8.46
- % of shares outstanding
- 8.95%
- Average daily volume
- 104.40K
- Change since last report
- −5.3%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.